This article in Forbes is interesting for its stranglehold on the obvious.
Noting that the shares of surgical device maker, Cardica, and gene therapy device maker, Cardium Therapeutics, have fallen of late, making them potential acquisition targets which, of course, virtually all med-tech companies are anyway. In fact, and to give Forbes credit, their point [...]
There is certainly the possibility (despite my doubts) that the current economic slowdown in global markets will have major effects on the medical technology industry. One simply cannot deny that there is simply less VC or other cash floating around that might be put to medtech investment. And maybe, as has occurred in [...]
In the Medtech Startups Database, we identify newly formed medical technology companies and capture as much data as possible on these sometimes secretive, “stealthy” companies. The companies we include are those that are predominantly, though not exclusively, device-intensive, but may also include those developing drug-device hybrids, biomaterials, biotech, drug or other technologies that are evolving [...]
The formation of medical technology companies has proceeded at a steady pace over the past few years. These largely device-intensive companies are pursuing a range of clinical applications that is progressively more diverse, encompassing materials science, application of various hybrid technologies and, ultimately, often dissolving boundaries between devices, diagnostics, biotech, pharma and other traditional product [...]
Another sampling of new technologies in various stages of development at recently founded medical technology startups:
Surgical drain and other technologies
Novel wound healing and drug delivery based on unique hydrogel
Nitric oxide coatings for blood-contacting medical devices
Bioresorbable implants for a range of surgical applications
Device to block transmission of pathogens via intravenous catheters
Self-expanding stent for femoral and popliteal [...]
The formation of new companies in any industry can be a true litmus of the overall health of the industry and an indicator of the direction the industry is taking through the relative balance of companies with different areas of focus. We present in a bar graph the number of medtech startup companies categorized by [...]
Below is the coverage in the April 2008 issue of MedMarkets.
Ablation: An Energized Market
Demand for Hip and Knee Implants Expected to Increase
MedMarket Outlook: Beyond Technology Innovation: Current and Future Market Forces and Trends
Early Stage Companies: Evalve, ES Vascular, Cardiorobotics, TriVascular
Early Stage Company Financings: Alure Medical, Arbel Medical, Breathe Technologies, CoAxia, IDev Technologies, IlluminOss [...]
We have just updated our “High Growth Medical Technologies” white paper, as we expect to continually do in the immediate future, since the areas with growth keep changing, and new areas keep appearing.
As all white papers should be, it’s free. Here’s the link so you can download it.
bookmark to
Compiling from our secret blend of information sources, we came across startups with the following new technologies in development:
Stents (tantalum, zirconium, niobium, and/or tungsten)
Mesh devices used to facilitate laparoscopic procedures.
Undisclosed technology
Minimally invasive removal of varicose veins and removal of the greater saphenous vein
Medtech platform company focused on cardiovascular and surgical applications
Medical device company launched by [...]
New medical technologies represented in companies added (March 2008) to the Medtech Startups Database and/or added to the March 2008 issue of MedMarkets:
Cardiac rhythm monitor.
Diagnosis of pediatric vesicoureteral reflux.
Developing atherectomy for peripheral vascular disease.
Systems to facilitate arthroscopic surgery.
Bioimplants for surgery.
Instrumentation for use in laparoscopic surgery.
Interbody spacers for spine surgery.
Electrosurgical instrumentation.
Drug startup
Pediatric therapeutics
Non-surgical treatment of obesity [...]